share_log

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga ·  Mar 20 13:31

Gainers

  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 95.8% to $2.04 during Wednesday's regular session. The company's market cap stands at $11.0 million.
  • Etao International Co (NASDAQ:ETAO) stock rose 84.65% to $0.26. The company's market cap stands at $26.6 million.
  • Annovis Bio (NYSE:ANVS) shares moved upwards by 39.12% to $12.41. The company's market cap stands at $131.2 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock increased by 33.28% to $0.47. The market value of their outstanding shares is at $23.2 million.
  • SCWorx (NASDAQ:WORX) stock moved upwards by 26.23% to $3.58. The company's market cap stands at $4.3 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) shares increased by 24.88% to $2.81. The market value of their outstanding shares is at $525.3 million. As per the news, the Q4 earnings report came out yesterday.

Losers

  • Lifecore Biomedical (NASDAQ:LFCR) stock declined by 31.4% to $4.93 during Wednesday's regular session. The company's market cap stands at $145.4 million.
  • Ontrak (NASDAQ:OTRK) shares fell 29.29% to $0.31. The market value of their outstanding shares is at $8.5 million.
  • Longeveron (NASDAQ:LGVN) stock fell 20.31% to $0.36. The market value of their outstanding shares is at $9.0 million.
  • Fresh2 Group (NASDAQ:FRES) stock decreased by 19.45% to $0.45. The market value of their outstanding shares is at $10.6 million.
  • Aptorum Gr (NASDAQ:APM) shares fell 18.07% to $7.89. The market value of their outstanding shares is at $40.8 million.
  • Seelos Therapeutics (NASDAQ:SEEL) stock decreased by 16.93% to $0.54. The market value of their outstanding shares is at $7.3 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment